Latest News and Press Releases
Want to stay updated on the latest news?
-
In the meeting with investors organized by Vilnius Stock Exchange that takes place on 18 September 2007, Invalda AB presents information about reorganization. Management of Invalda AB estimates...
-
BILLERICA, MA--(Marketwire - September 18, 2007) - Trillium Software®, a business of Harte-Hanks, Inc. (NYSE: HHS), and a leading enabler of Total Data Quality solutions, today announced the...
-
ATLANTA, Sept. 18, 2007 (PRIME NEWSWIRE) -- Delta Air Lines (NYSE:DAL) continues growing with new nonstop daily flights from LaGuardia International Airport to Bermuda, starting in April of...
-
Implementation of the Center of Excellence in Water Industry Clusters (CEWIC) in Oulu took a significant step forward when the Oulu City Board allocated EUR 750,000 of the city's funds to its...
-
Clean Energy (CLNE) Founder and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
ADVISORY, Sept. 18, 2007 (PRIME NEWSWIRE) -- What: T. Boone Pickens, Founder, and Andrew Littlefair, President and Chief Executive Officer of Clean Energy (CLNE), will preside over the...
-
HOUSTON, TX--(Marketwire - September 18, 2007) - Petro Resources Corporation (the "Company") (AMEX: PRC) provides an update on exploration and production activity. Williston Basin North Dakota...
-
ONTARIO, Calif., Sept. 18, 2007 (PRIME NEWSWIRE) -- SOYO Group Inc. (OTCBB:SOYO), an innovative provider of computer, consumer electronics and broadband telecommunications products, announced today...
-
BARRIE, Ontario, Sept. 18, 2007 (PRIME NEWSWIRE) -- 1ShoppingCart, the online shopping cart and marketing application services provider, today releases the next generation of its eCommerce platform....
-
Biohit Oyj has begun to test market the XyliCyst chewing gum, a functional food product, through an online shop (www.verkkoapteekki.fi). At this stage, it is difficult to estimate the impact of...
-
Three Investigational New Drugs (IND) in Pipeline - Phase II HIV Drug SP-01A - Phase I Alzheimer's Drug SP-233 Caprospinol - Phase II Cushing's syndrome SP-6300 LAS VEGAS, Sept. 18, 2007...